Pregabalin-associated myoclonic encephalopathy without evidence of drug accumulation in a patient with acute renal failure
Pregabalin, used for treating partial epilepsy and neuropathic pain, is usually well tolerated. Patients with impaired renal function are at risk to develop more serious adverse events. A 64-year-old woman was admitted in the Emergency Department for altered consciousness and abnormal movements. She...
Main Authors: | F Courtois, D Borrey, V Haufroid, P Hantson |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2014-01-01
|
Series: | Indian Journal of Nephrology |
Subjects: | |
Online Access: | http://www.indianjnephrol.org/article.asp?issn=0971-4065;year=2014;volume=24;issue=1;spage=48;epage=50;aulast=Courtois |
Similar Items
-
Negative myoclonus associated with pregabalin
by: Kwan-Do Park, et al.
Published: (2018-12-01) -
Nasal pregabalin overdose and myclonus: a new way of misuse
by: H. Mihrimah Ozturk, et al.
Published: (2019-04-01) -
To evaluate efficacy of pregabalin for the prevention of etomidate-induced myoclonus: A prospective, randomized, placebo-controlled, double-blind study
by: Vinit Kumar Srivastava, et al.
Published: (2021-01-01) -
Myoclonic Disorders
by: Olaf Eberhardt, et al.
Published: (2017-08-01) -
Prolonged encephalopathy and associated nonconvulsive seizures from suspected pregabalin and tapentadol: Two case reports and review of literature
by: Kavi Haji, et al.
Published: (2021-03-01)